Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Single-arm Phase 3B Implementation Study to Monitor the Effectiveness of the Single-dose Ad26.COV2.S COVID-19 Vaccine Among Health Care Workers in South Africa (VAC31518COV3012)

NCT04838795 is registered in ClinicalTrials.gov with Wits Health Consortium (Pty) Ltd as lead sponsor.

NCT NCT04838795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04838795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Single-arm Phase 3B Implementation Study to Monitor the Effectiveness of the Single-dose Ad26.COV2.S COVID-19 Vaccine Among Health Care Workers in South Africa (VAC31518COV3012)
Lead sponsor
Wits Health Consortium (Pty) Ltd
Phase
Phase 3
Overall status
Completed
Start date
February 17, 2021
Completion date
March 31, 2022
Enrollment
477,102 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

sars (severe acute respiratory syndrome)